211 related articles for article (PubMed ID: 23798714)
1. CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease.
Coghill JM; Fowler KA; West ML; Fulton LM; van Deventer H; McKinnon KP; Vincent BG; Lin K; Panoskaltsis-Mortari A; Cook DN; Blazar BR; Serody JS
Blood; 2013 Aug; 122(5):825-36. PubMed ID: 23798714
[TBL] [Abstract][Full Text] [Related]
2. A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease.
Tawara I; Shlomchik WD; Jones A; Zou W; Nieves E; Liu C; Toubai T; Duran-Struuck R; Sun Y; Clouthier SG; Evers R; Lowler KP; Levy RB; Reddy P
J Immunol; 2010 Oct; 185(7):3866-72. PubMed ID: 20810991
[TBL] [Abstract][Full Text] [Related]
3. Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients.
Yi T; Li X; Yao S; Wang L; Chen Y; Zhao D; Johnston HF; Young JS; Liu H; Todorov I; Forman SJ; Chen L; Zeng D
J Immunol; 2011 Mar; 186(5):2739-49. PubMed ID: 21263067
[TBL] [Abstract][Full Text] [Related]
4. Third-party regulatory T cells prevent murine acute graft-versus-host disease.
Lim JY; Im KI; Song Y; Kim N; Nam YS; Jeon YW; Cho SG
Korean J Intern Med; 2018 Sep; 33(5):980-989. PubMed ID: 29050459
[TBL] [Abstract][Full Text] [Related]
5. Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice.
Ganguly S; Ross DB; Panoskaltsis-Mortari A; Kanakry CG; Blazar BR; Levy RB; Luznik L
Blood; 2014 Sep; 124(13):2131-41. PubMed ID: 25139358
[TBL] [Abstract][Full Text] [Related]
6. Donor- but not host-derived interleukin-10 contributes to the regulation of experimental graft-versus-host disease.
Tawara I; Sun Y; Liu C; Toubai T; Nieves E; Evers R; Alrubaie M; Mathewson N; Tamaki H; Reddy P
J Leukoc Biol; 2012 Apr; 91(4):667-75. PubMed ID: 22262800
[TBL] [Abstract][Full Text] [Related]
7. Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models.
Florek M; Sega EI; Leveson-Gower DB; Baker J; Müller AM; Schneidawind D; Meyer E; Negrin RS
Blood; 2014 Sep; 124(11):1832-42. PubMed ID: 25030062
[TBL] [Abstract][Full Text] [Related]
8. Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease.
Kim BS; Nishikii H; Baker J; Pierini A; Schneidawind D; Pan Y; Beilhack A; Park CG; Negrin RS
Blood; 2015 Jul; 126(4):546-57. PubMed ID: 26063163
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
11. The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease.
McDonald-Hyman C; Muller JT; Loschi M; Thangavelu G; Saha A; Kumari S; Reichenbach DK; Smith MJ; Zhang G; Koehn BH; Lin J; Mitchell JS; Fife BT; Panoskaltsis-Mortari A; Feser CJ; Kirchmeier AK; Osborn MJ; Hippen KL; Kelekar A; Serody JS; Turka LA; Munn DH; Chi H; Neubert TA; Dustin ML; Blazar BR
J Clin Invest; 2018 Oct; 128(10):4604-4621. PubMed ID: 30106752
[TBL] [Abstract][Full Text] [Related]
12. DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease.
Nishikii H; Kim BS; Yokoyama Y; Chen Y; Baker J; Pierini A; Alvarez M; Mavers M; Maas-Bauer K; Pan Y; Chiba S; Negrin RS
Blood; 2016 Dec; 128(24):2846-2858. PubMed ID: 27760760
[TBL] [Abstract][Full Text] [Related]
13. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
[TBL] [Abstract][Full Text] [Related]
14. Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease.
Velaga S; Ukena SN; Dringenberg U; Alter C; Pardo J; Kershaw O; Franzke A
PLoS One; 2015; 10(4):e0124927. PubMed ID: 25928296
[TBL] [Abstract][Full Text] [Related]
15. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS
J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967
[TBL] [Abstract][Full Text] [Related]
16. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
[TBL] [Abstract][Full Text] [Related]
17. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
Front Immunol; 2018; 9():3104. PubMed ID: 30733722
[TBL] [Abstract][Full Text] [Related]
18. Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD.
MacDonald KP; Kuns RD; Rowe V; Morris ES; Banovic T; Bofinger H; O'Sullivan B; Markey KA; Don AL; Thomas R; Hill GR
Blood; 2007 Jun; 109(11):5049-57. PubMed ID: 17327399
[TBL] [Abstract][Full Text] [Related]
19. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
Drobyski WR; Majewski D
Blood; 1996 Jun; 87(12):5355-69. PubMed ID: 8652851
[TBL] [Abstract][Full Text] [Related]
20. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.
Taylor PA; Panoskaltsis-Mortari A; Swedin JM; Lucas PJ; Gress RE; Levine BL; June CH; Serody JS; Blazar BR
Blood; 2004 Dec; 104(12):3804-12. PubMed ID: 15292057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
